Related references
Note: Only part of the references are listed.Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAG, Tanespimycin) in Glioblastoma Cells
Nathatie Gaspar et al.
CANCER RESEARCH (2009)
DNA repair and cancer stem-like cells - Potential partners in glioma drug resistance?
Tor-Christian Aase Johannessen et al.
CANCER TREATMENT REVIEWS (2008)
Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma
Jonathon F. Parkinson et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma
Eli E. Bar et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas
Emily C. Brantley et al.
MOLECULAR CANCER RESEARCH (2008)
Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma
Johan Rebetz et al.
PLOS ONE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma
Nicola Potter et al.
NEOPLASIA (2008)
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors - A report from the children's oncology group
H. Stacy Nicholson et al.
CANCER (2007)
MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas
Judith Wm Jeuken et al.
LABORATORY INVESTIGATION (2007)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
Molecular pathogenesis of pediatric astrocytic tumors
Mitsutoshi Nakamura et al.
NEURO-ONCOLOGY (2007)
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors
Damien Faury et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children
Alberto Broniscer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Interleukin-6 gene amplification and shortened survival in glioblastoma patients
A. Tchirkov et al.
BRITISH JOURNAL OF CANCER (2007)
Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array
Kwong-Kwok Wong et al.
CANCER RESEARCH (2006)
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2006)
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas
John P. Fruehauf et al.
CLINICAL CANCER RESEARCH (2006)
O6-Methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas:: Results from the CCG-945 cohort
Ian F. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Unlocking pathology archives for molecular genetic studies:: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization
MBK Lambros et al.
LABORATORY INVESTIGATION (2006)
Phase II trial of temozolomide in children with recurrent high-grade glioma
A. Ruggiero et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children
A Broniscer et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Transforming growth factor-beta: A molecular target for the future therapy of glioblastoma
W Wick et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines
MS Bobola et al.
CLINICAL CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences
AOH Nygren et al.
NUCLEIC ACIDS RESEARCH (2005)
Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas
W Krupp et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma
AR Stone et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance
JG Ma et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases
CH Rickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
